Cyrus V. Desouza, MD, MBBS
Professor and ChiefDepartment of Diabetes, Endocrinology and MetabolismUniversity of Nebraska Medical CenterOmaha, Nebraska
W. Timothy Garvey, MD
Professor and ChairDepartment of Nutrition SciencesUniversity of Alabama at BirminghamBirmingham, Alabama
Carla J. Greenbaum, MD
DirectorDiabetes Clinical Research ProgramBenaroya Research Institute at Virginia MasonSeattle, Washington
Sandra M. Lord, MD
Clinical Research AssociateDiabetes Clinical Research ProgramBenaroya Research Institutue at Virginia MasonSeattle, Washington
Anne L. Peters, MD
ProfessorUniversity of Southern CaliforniaKeck School of MedicineDirectorUSC Clinical Diabetes ProgramLos Angeles, California
Vivian A. Fonseca, MD, FRCP has received honoraria from Abbott Laboratories, Amgen, Astra Zeneca, Boehringer Ingelheim, Eli Lilly and Company, Janssen Pharmaceuticals, Inc., Novo Nordisk, Inc, Pamlabs, Sanofi-aventis, and Takeda Pharmaceuticals; and has conducted contracted research for Abbott Laboratories, Asahi Kasei Pharma Corp., Eli Lilly and Company, Endo Barrier, Gilead Sciences, and Novo Nordisk, Inc.
Cyrus V. Desouza, MD, MBBS has received salary/honoraria from Takeda Pharmaceutical Company Limited; and consulting fees from Novo Nordisk.
W. Timothy Garvey, MD has received honoraria from LipoScience Inc and Merck & Co, Inc; has received consulting fees from Alkermes, Daiichi Sankyo Inc, Janssen Pharmaceuticals, Johnson & Johnson Inc, LipoScience Inc, and Vivus Inc; has conducted contracted research for Amylin Pharmaceuticals, Merck & Co, Inc, and Weight Watchers; and has ownership interest in Bristol-Myers Squibb, Eli Lilly and Company, Institute for Science and International Security, Merck & Co, Inc, Novartis Pharmaceuticals Corporation, Otsuka Pharmaceuticals, and Vivus Inc.
Carla J. Greenbaum, MD has received consulting fees from Bristol-Myers Squibb and has conducted contracted research for Janssen and Novo Nordisk.
Sandra M. Lord, MD
Anne L. Peters, MD has received salary/honoraria from AstraZeneca/Bristol-Myers Squibb and Novo Nordisk Pharmaceuticals, Inc.; and consulting fees from Abbott Diabetes Care, AstraZeneca/Bristol-Myers Squibb, Becton, Dickinson and Company, Boehringer Ingelheim, Eli Lilly and Company, Janssen Pharmaceuticals, Medtronic MiniMed, Inc., Sanofi-Aventis, and Takeda Pharmaceutical Company Limited.